Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA-based vaccines for allergic disease.

Hans L Spiegelberg1, Kenji Takabayashi, Lucinda Beck

  • 1Department of Pediatrics, University of California, San Diego School of Medicine, La Jolla 92093-0833, USA. hansspiege@aol.com

Expert Review of Vaccines
|August 7, 2003
PubMed
Summary

New allergen immunotherapy methods, including gene vaccination and DNA conjugates, show promise for safe and effective allergy treatment by modulating immune responses. These approaches aim to reduce adverse reactions associated with traditional methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omics profiling reveals microenvironmental remodeling as a key driver of house dust mite-induced lung cancer progression.

Neoplasia (New York, N.Y.)·2026
Same author

Single-cell transcriptomics reveals immune remodeling of the murine lung microenvironment following chronic house dust mite exposure.

Frontiers in immunology·2025
Same author

Efficient Workflows for Quantifying Tumor Growth on H&E-Stained Digital Sections in Mouse Models of Lung Cancer.

Current protocols·2025
Same author

Multi-omics profiling reveals microenvironmental remodeling as a key driver of house dust mite-induced lung cancer progression.

bioRxiv : the preprint server for biology·2025
Same author

Myeloid cAMP Reduction Shifts Rhinovirus-Induced Airway Inflammation From Neutrophilic to Eosinophilic by Suppressing M1-Interstitial Macrophages.

Allergy·2025
Same author

RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer.

Cancer immunology research·2025

Area of Science:

  • Immunology
  • Allergy Research
  • Vaccine Development

Background:

  • Traditional allergen-specific immunotherapy (AIT) is effective but limited by adverse reactions.
  • Novel AIT approaches aim to improve safety and efficacy.
  • Allergen gene vaccination and allergen-immunostimulatory DNA conjugates are emerging strategies.

Purpose of the Study:

  • To evaluate the efficacy and safety of novel allergen immunotherapy approaches.
  • To investigate the immune response modulation by new AIT methods.
  • To assess the potential of allergen-immunostimulatory DNA conjugates in clinical settings.

Main Methods:

  • Utilized animal models of allergy to test allergen gene vaccination and DNA conjugate vaccines.
  • Assessed the induction of T-helper cell type 1 (Th1) and downregulation of T-helper cell type 2 (Th2) responses.

Related Experiment Videos

  • Conducted initial clinical trials with allergic patients using allergen-immunostimulatory DNA conjugates.

    • Main Results:

    • Both novel methods induced nonallergic Th1 immune responses to allergens in animal models.
    • Pre-existing Th2 responses were downregulated by these new vaccination strategies.
    • Allergen-immunostimulatory DNA conjugates were well-tolerated in clinical trials, inducing IgG but not IgE antibodies.

    Conclusions:

    • Allergen gene vaccination and DNA conjugates represent promising, safer alternatives to traditional AIT.
    • These novel immunotherapies effectively modulate the immune system to combat allergies.
    • Further clinical development of allergen-immunostimulatory DNA conjugates is warranted for safe and effective allergy treatment.